KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Depreciation & Amortization (CF) (2018 - 2019)

Historic Depreciation & Amortization (CF) for Novartis Ag (NVS) over the last 14 years, with Q3 2022 value amounting to $2.1 billion.

  • Novartis Ag's Depreciation & Amortization (CF) rose 4636.68% to $2.1 billion in Q3 2022 from the same period last year, while for Jun 2023 it was $2.1 billion, marking a year-over-year decrease of 2835.37%. This contributed to the annual value of $6.9 billion for FY2018, which is 867.02% up from last year.
  • According to the latest figures from Q3 2022, Novartis Ag's Depreciation & Amortization (CF) is $2.1 billion, which was up 4636.68% from $1.5 billion recorded in Q1 2022.
  • Novartis Ag's Depreciation & Amortization (CF)'s 5-year high stood at $2.1 billion during Q3 2022, with a 5-year trough of $930.0 million in Q1 2018.
  • For the 5-year period, Novartis Ag's Depreciation & Amortization (CF) averaged around $1.6 billion, with its median value being $1.5 billion (2022).
  • In the last 5 years, Novartis Ag's Depreciation & Amortization (CF) plummeted by 4763.51% in 2018 and then surged by 5623.66% in 2019.
  • Novartis Ag's Depreciation & Amortization (CF) (Quarter) stood at $2.0 billion in 2018, then decreased by 28.74% to $1.5 billion in 2019, then decreased by 0.28% to $1.4 billion in 2020, then dropped by 0.28% to $1.4 billion in 2021, then surged by 46.37% to $2.1 billion in 2022.
  • Its Depreciation & Amortization (CF) was $2.1 billion in Q3 2022, compared to $1.5 billion in Q1 2022 and $1.4 billion in Q3 2021.